Ropca
Ropca is a Denmark-based AI company, founded in 2019, developing automated medical ultrasound devices intended for the diagnosis of arthritis. It serves the rheumatology and clinical diagnostics market with an AI-driven imaging interpretation product.
- Company typePrivate
- Founded2019
- HeadquartersOdense, Denmark
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What Ropca does
Ropca is a Denmark-based artificial intelligence company, founded in 2019 in Odense, that develops automated medical ultrasound devices intended for the diagnosis of arthritis. The company's value proposition centers on applying AI to automate ultrasound imaging interpretation, addressing the manual-expertise bottleneck in arthritis diagnosis where clinical decisions today depend on trained rheumatologists or radiologists performing and reading scans. The product is positioned as a medical device, implying it operates in a regulated environment requiring conformity assessment and clinical validation before commercial deployment.
The company is at an early stage: headcount is reported at 1-10 employees, no funding rounds, partnerships, certifications, patents, named customers, or product-level technical specifications are disclosed in the available source data. The company website currently renders only a verification/loading screen, limiting public visibility into product architecture, pricing, go-to-market, and distribution. Leadership is limited to a single disclosed executive, Johannes Schaeferhoff as Chief Executive Officer.
No revenue model, pricing structure, customer segments, or go-to-market channels are documented. Given the medical-device nature of the product, plausible commercialization paths would include direct sales to hospitals and rheumatology clinics, distribution through medical-imaging OEMs, or a software-as-a-medical-device (SaMD) licensing model — but none of these are confirmed in the source data. The investment picture is therefore nascent: a focused AI medical-device thesis in a real clinical need area, but with very limited disclosed evidence of execution milestones, capital raised, or commercial traction.
Ropca firmographics
Firmographics- Name
- Ropca
- Website
- https://ropca.com
- Company type
- Private
- Founded year
- 2019
- Headcount range
- 1–10 employees
- Short description
- Ropca is a Denmark-based AI company, founded in 2019, developing automated medical ultrasound devices intended for the diagnosis of arthritis. It serves the rheumatology and clinical diagnostics market with an AI-driven imaging interpretation product.
- Ownership category
- akta.pro rank
Ropca industry classification
Industry- Product category
- Medical Imaging Devices
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Ultrasound & Echography Systems (HLAHABAD)
- akta.pro secondary industries
- Medical Imaging AI (HDAAAEAH), SaMD – Imaging & Signal Analysis (AI/ML) (HLACANAG), Portable, Mobile & Point-of-Care Imaging Systems (HLAHABAL)
Keywords
Where Ropca is headquartered
LocationHeadquarters
- HQ city
- Odense
- HQ country
- Denmark
- HQ region
- Europe
Markets served
Ropca business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Supply Chain, Personnel, Operations
Ropca product offering
Product offeringCore offering
Ropca develops automated medical ultrasound devices powered by artificial intelligence for the diagnosis of arthritis. The company combines purpose-built ultrasound hardware with AI-based image analysis to enable automated detection and assessment of arthritic conditions, targeting clinical and healthcare use cases.
Differentiator
Problem solved
Functional benefit
Products and services
- Automated Medical Ultrasound Device for Arthritis Diagnosis
Companies that use Ropca
Customer profileIdeal customer profiles1 record
Ropca technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Ropca partnerships and signals
Strategic signalRecent moves2 records
Ropca competitors and assessment
Company assessmentDirect peers
- Butterfly Network: Maker of a handheld, AI-enabled ultrasound probe and software platform used across multiple clinical indications including musculoskeletal. Directly comparable to Ropca on the convergence of portable ultrasound hardware and embedded AI for image interpretation.
- Clarius Mobile Health: Develops handheld, smartphone-connected ultrasound scanners with AI-assisted imaging presets, including musculoskeletal workflows. Closely comparable to Ropca as a portable, AI-assisted ultrasound vendor pursuing non-radiologist users.
Broad incumbents
- GE HealthCare: One of the largest ultrasound OEMs globally, with a broad LOGIQ and Venue portfolio and an expanding AI musculoskeletal imaging roadmap. Represents the incumbent competitive backdrop against which a focused AI-ultrasound startup must differentiate.
- Philips: Major imaging OEM with ultrasound systems and AI-driven quantification tools used in musculoskeletal and point-of-care settings. Comparable as an incumbent defining the standard of care Ropca's automation play must displace or complement.
- Siemens Healthineers: Global ultrasound and imaging OEM with AI-enabled MSK and joint assessment features across its ACUSON portfolio. Relevant incumbent peer shaping clinical expectations for AI-assisted MSK imaging.
- Samsung Medison: OEM of diagnostic ultrasound systems with AI musculoskeletal packages and growing presence in compact and point-of-care form factors. Comparable as an established player expanding into the same AI-ultrasound territory Ropca targets.
- Mindray: Diversified medical device manufacturer with a strong ultrasound portfolio increasingly incorporating AI features. Comparable as a global OEM competing on price-performance in musculoskeletal and point-of-care ultrasound.
Emerging players
- Arterys: Cloud-native AI imaging analytics platform with FDA-cleared algorithms across multiple modalities. Comparable as a specialist in AI interpretation layers that could be deployed alongside or in competition with Ropca's ultrasound AI.
- Viz.ai: Specialist in AI-driven clinical imaging workflows with regulatory clearances for triage and notification. Comparable as a regulated, AI-first imaging software company whose commercialization playbook is informative for Ropca.
- Esaote: European-headquartered ultrasound specialist with deep roots in musculoskeletal and rheumatology imaging. Closely comparable given overlapping clinical focus (MSK/rheumatology) and its European footprint adjacent to Ropca's Danish base.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat3 records
Key risks4 records
Key highlights4 records
Customer concentration
Ropca social profiles
Digital presenceRopca financial estimates
Financial estimateRevenue estimate
Valuation estimate
Ropca leadership team
Management profileNumber of profiles
Profiles1 record
Ropca funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Ropca M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Ropca
What does Ropca do?
Ropca develops automated medical ultrasound devices powered by artificial intelligence for the diagnosis of arthritis. The company combines purpose-built ultrasound hardware with AI-based image analysis to enable automated detection and assessment of arthritic conditions, targeting clinical and healthcare use cases.
When was Ropca founded?
Ropca was founded in 2019. It employs 1 to 10 people.
Where is Ropca based?
Ropca is headquartered in Odense, Denmark, in the Europe region.
Who are Ropca's main competitors?
Direct peers on record are Butterfly Network and Clarius Mobile Health. Broad incumbents are GE HealthCare, Philips, Siemens Healthineers, Samsung Medison and Mindray. Emerging players are Arterys, Viz.ai and Esaote.
Does Ropca have an API?
No public API is recorded for Ropca.
What industry is Ropca in?
Ropca's product category is Medical Imaging Devices. Its primary akta.pro industry code is HLAHABAD, Ultrasound & Echography Systems, with a secondary code of HDAAAEAH, Medical Imaging AI. Its NAICS code is 334510 and its SIC code is 3845.